MedPath

SEPIA

Sevene USA (as PLD) - SEPIA 200ck (76472-3033)

Approved
Approval ID

cf899437-d40b-1969-e053-2a95a90a03be

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 22, 2025

Manufacturers
FDA

SEVENE USA

DUNS: 969332936

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SEPIA

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76472-3033
Product Classification
G
Generic Name
SEPIA
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateMay 22, 2025
FDA Product Classification

INGREDIENTS (2)

SUCROSEInactive
Code: C151H8M554
Classification: IACT
SEPIA OFFICINALIS JUICEActive
Quantity: 200 [kp_C] in 1 1
Code: QDL83WN8C2
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/9/2017

sepia 200k p1sepia 200k p2sepia 200k p3

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 2/21/2018

USE

Condition listed above or as directed by a physician.

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 11/23/2011

Do not use if pellet-dispenser seal is broken.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 2/21/2018

INACTIVE INGREDIENT

Sucrose.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 2/21/2018

QUESTIONS?

INFO@OLLOIS.COM * www.ollois.com * MADE IN FRANCE. NOT REVIEWED BY THE FDA AND NOT GUARANTEED TO BE EFFECTIVE. THIS HOMEOPATHIC DILUTION MAY NOT BE SUSCEPTIBLE TO SCIENTIFIC MEASUREMENT.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 2/21/2018

ACTIVE INGREDIENT

HOMEOPATHIC DILUTION OF HPUS SEPIA 200ck**C,K, CK, AND X ARE HOMEOPATHIC DILUTIONS.

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 2/21/2018

TRADITIONALLY USED FOR

Stinging edemas from stings or allergies, relieved by cold*

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 2/21/2018

DIRECTIONS

(adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

WARNINGS SECTION

LOINC: 34071-1Updated: 2/21/2018

WARNINGS

Stop use and ask a physician if symptoms persist for more than 3 days or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 11/23/2011

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 11/23/2011

Keep out of reach of children.

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 2/21/2018

OTHER INFORMATION

Store at room temperature.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SEPIA - FDA Drug Approval Details